Requirement of additional adenylate cyclase activation for the inhibition of human eosinophil degranulation by phosphodiesterase IV inhibitors. [electronic resource]
Producer: 20010719Description: 11-8 p. digitalISSN:- 0014-2999
- 3',5'-Cyclic-AMP Phosphodiesterases -- antagonists & inhibitors
- Adenylyl Cyclases -- metabolism
- Adult
- Albuterol -- pharmacology
- Benzamides -- pharmacology
- Cell Degranulation -- drug effects
- Colforsin -- pharmacology
- Cyclic AMP -- metabolism
- Cyclic Nucleotide Phosphodiesterases, Type 4
- Cyclohexanecarboxylic Acids -- pharmacology
- Dinoprostone -- pharmacology
- Dose-Response Relationship, Drug
- Enzyme Activation -- drug effects
- Eosinophil Peroxidase
- Eosinophils -- drug effects
- Histamine -- pharmacology
- Humans
- Nitriles
- Peroxidases -- drug effects
- Phosphodiesterase Inhibitors -- pharmacology
- Pyridines -- pharmacology
- Rolipram -- pharmacology
- Superoxides -- metabolism
- Theophylline -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.